Overview

Towards Cure Via Only Ultra-short ICB in CSCC

Status:
RECRUITING
Trial end date:
2029-02-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to determine whether cutaneous squamous cell carcinoma patients can be cured using only immunotherapy, without surgery or radiotherapy.
Phase:
PHASE2
Details
Lead Sponsor:
The Netherlands Cancer Institute
Collaborators:
Amsterdam UMC, location VUmc
Erasmus Medical Center
Maastricht University Medical Center
UMC Utrecht
Treatments:
Immunotherapy
Nivolumab